🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for High Risk Smoldering Multiple Myeloma

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial NCT06212323n/a1 site📍 Salt Lake City University of Utah · Tests: Patients with smoldering myeloma undergoing active surveillance with diffusion weighted whole body MRI. A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma NCT06140524Phase 239 sites📍 Baltimore📍 Boston📍 Ann Arbor Regeneron Pharmaceuticals · Tests: Linvoseltamab The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma NCT05841550Phase 1, Phase 21 site📍 Oslo Oslo University Hospital · Tests: TG01 A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma NCT05055063Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Belantamab mafodotin Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma NCT03937635Phase 3748 sites📍 Birmingham📍 Anchorage📍 Anchorage ECOG-ACRIN Cancer Research Group · Tests: Daratumumab, Dexamethasone, Lenalidomide, Quality-of-Life Assessment, Questionnaire Administration Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma NCT04776395Phase 21 site📍 Atlanta Emory University · Tests: Dexamethasone, Iberdomide Hydrochloride, Quality-of-Life Assessment A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM) NCT07393282Phase 327 sites📍 Phoenix📍 Atlanta📍 Boston Regeneron Pharmaceuticals · Tests: Linvoseltamab, Daratumumab Immuno-PRISM (PRecision Intervention Smoldering Myeloma) NCT05469893Phase 23 sites📍 Denver📍 Boston📍 Portland Irene Ghobrial, MD · Tests: Teclistamab, Lenalidomide, Dexamethasone A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma NCT06768489Phase 116 sites📍 Denver📍 Atlanta📍 Clayton Janssen Research & Development, LLC · Tests: JNJ-79635322, Daratumumab, Pomalidomide, Lenalidomide BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma NCT06745687NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: CM336 Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma NCT05597345Phase 21 site📍 Rochester University of Rochester · Tests: Selinexor Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma NCT06762769Phase 214 sites📍 Leeds📍 Oxford📍 Aberdeen University College, London · Tests: Isatuximab, Iberdomide, Dexamethasone Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma NCT06574126Phase 21 site📍 Salamanca PETHEMA Foundation · Tests: Group 1: Dara-VRD followed by apheresis and cilta-cel infusion, Group 2: Apheresis followed by Dara-VRD and cilta-cel i… Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study) NCT06100237Phase 21 site📍 Miami Carl Ola Landgren, MD, PhD · Tests: Teclistamab, Talquetamab, Daratumumab SC
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy